Expert Rev Proteomics. 2005 Jun;2(3):337-48.

Morphoproteomics: exposing protein circuitries in tumors to identify potential therapeutic targets in cancer patients.

Source

Geisinger Medical Center, Danville, PA 17822-0131, USA. rebrown@geisinger.edu

Abstract

Morphoproteomics combines the disciplines of histopathology, molecular biology and protein chemistry to paint a portrait of the protein circuitry in diseased cells for the purpose of uncovering molecular targets amenable to specific intervention, thereby customizing therapy for individual patients. This review considers the clinical application of morphoproteomics in malignant cells in the context of currently available pharmaceutical agents and discusses opportunities for combinatorial approaches that involve one or more small molecule inhibitors and single-agent chemotherapy with relatively low toxicity profiles. Future directions that involve focusing on points of convergence in signal transduction pathways and which integrate morphoproteomic with genomic and pharmacoproteomic and protein-function microarray data are offered.

PMID:: 16000081; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

Neoplasm Proteins

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Cancer - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Review [Development of antituberculous drugs: current status and future prospects]. [Kekkaku. 2006]
Review [Development of antituberculous drugs: current status and future prospects].
Tomioka H, Namba K. Kekkaku. 2006 Dec; 81(12):753-74.
Review What does systems biology mean for drug development? [Curr Med Chem. 2008]
Review What does systems biology mean for drug development?
Schrattenholz A, Soskić V. Curr Med Chem. 2008; 15(15):1520-8.
Review Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy. [J Clin Oncol. 2005]
Review Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.
Petricoin EF 3rd, Bichsel VE, Calvert VS, Espina V, Winters M, Young L, Belluco C, Trock BJ, Lippman M, Fishman DA, et al. J Clin Oncol. 2005 May 20; 23(15):3614-21.
Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells. [J Proteome Res. 2006]
Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells.
Chen YR, Juan HF, Huang HC, Huang HH, Lee YJ, Liao MY, Tseng CW, Lin LL, Chen JY, Wang MJ, et al. J Proteome Res. 2006 Oct; 5(10):2727-42.
Review Genomics of prostate cancer: is there anything to "translate"? [Pathol Oncol Res. 2005]
Review Genomics of prostate cancer: is there anything to "translate"?
Kopper L, Tímár J. Pathol Oncol Res. 2005; 11(4):197-203. Epub 2005 Dec 31.

See reviews... See all...

Cited by 4 PubMed Central articles

Morphoproteomic confirmation of an activated nuclear factor-кBp65 pathway in follicular thyroid carcinoma. [Int J Clin Exp Pathol. 2012]
Morphoproteomic confirmation of an activated nuclear factor-кBp65 pathway in follicular thyroid carcinoma.
Liu J, Brown RE. Int J Clin Exp Pathol. 2012; 5(3):216-23. Epub 2012 Mar 25.
Targeted morphoproteomic profiling of Ewing's sarcoma treated with insulin-like growth factor 1 receptor (IGF1R) inhibitors: response/resistance signatures. [PLoS One. 2011]
Targeted morphoproteomic profiling of Ewing's sarcoma treated with insulin-like growth factor 1 receptor (IGF1R) inhibitors: response/resistance signatures.
Subbiah V, Naing A, Brown RE, Chen H, Doyle L, LoRusso P, Benjamin R, Anderson P, Kurzrock R. PLoS One. 2011 Apr 6; 6(4):e18424. Epub 2011 Apr 6.
Tissue-microarray based immunohistochemical analysis of survival pathways in nodular sclerosing classical Hodgkin lymphoma as compared with Non-Hodgkin's lymphoma. [Int J Clin Exp Med. 2010]
Tissue-microarray based immunohistochemical analysis of survival pathways in nodular sclerosing classical Hodgkin lymphoma as compared with Non-Hodgkin's lymphoma.
De J, Brown RE. Int J Clin Exp Med. 2010 Jan 30; 3(1):55-68. Epub 2010 Jan 30.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Morphoproteomics: exposing protein circuitries in tumors to identify potential t...
Morphoproteomics: exposing protein circuitries in tumors to identify potential therapeutic targets in cancer patients.
Expert Rev Proteomics. 2005 Jun ;2(3):337-48.

PubMed
Subcortical brain anatomy in anorexia and bulimia.
Subcortical brain anatomy in anorexia and bulimia.
Biol Psychiatry. 1992 Apr 1 ;31(7):735-8.

PubMed
The effect of phytic acid on the levels of blood glucose and some enzymes of car...
The effect of phytic acid on the levels of blood glucose and some enzymes of carbohydrate and lipid metabolism.
West Indian Med J. 2005 Mar ;54(2):102-6.

PubMed
Fluvoxamine improves negative symptoms in treated chronic schizophrenia: an add-...
Fluvoxamine improves negative symptoms in treated chronic schizophrenia: an add-on double-blind, placebo-controlled study.
Biol Psychiatry. 1992 Apr 1 ;31(7):698-704.

PubMed
Evaluation and management of apparent life-threatening events in children.
Evaluation and management of apparent life-threatening events in children.
Am Fam Physician. 2005 Jun 15 ;71(12):2301-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: